![Mihael Polymeropoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mihael Polymeropoulos
Algemeen Directeur bij
VANDA PHARMACEUTICALS INC.
Vermogen: 10 M $ op 31-05-2026
Profiel
Mihael Hristos Polymeropoulos is the founder of Vanda Pharmaceuticals, Inc., founded in 2002.
Titles held at Vanda Pharmaceuticals, Inc. include Chairman, President & Chief Executive Officer since 2021.
Dr. Polymeropoulos is also the founder of Integrated Molecular Analysis of Genome Expression..
Former jobs include VP & Head-Pharmacogenetics Department at Novartis AG from 1998 to 2003 and Chief-Gene Mapping Section at National Human Genome Research Institute from 1992 to 1998.
Education includes undergraduate studies at the University of Patras.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-04-2026 | 1.588.246 ( 2,64% ) | 10 M $ | 31-05-2026 |
Actieve functies van Mihael Polymeropoulos
| Bedrijven | Functie | Begin |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Algemeen Directeur | 01-05-2003 |
Eerdere bekende functies van Mihael Polymeropoulos
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01-01-2003 |
National Human Genome Research Institute
 National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Corporate Officer/Principal | 01-01-1998 |
Integrated Molecular Analysis of Genome Expression | Oprichter | - |
Opleiding van Mihael Polymeropoulos
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
65
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Patras
 University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Integrated Molecular Analysis of Genome Expression | |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Government |
